4.1 Article

Cassiae Semen improves non-alcoholic fatty liver disease through autophagy-related pathway

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Quercetin Reduces Lipid Accumulation in a Cell Model of NAFLD by Inhibiting De Novo Fatty Acid Synthesis through the Acetyl-CoA Carboxylase 1/AMPK/PP2A Axis

Antonio Gnoni et al.

Summary: The dysregulation of de novo lipogenesis (DNL) is considered a critical factor in the assessment of non-alcoholic fatty liver disease (NAFLD). Our study found that high glucose and free fatty acid conditions resulted in the highest cellular lipid accumulation. Quercetin exhibited an anti-lipogenic effect by inhibiting the DNL pathway.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Nutrition & Dietetics

Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis

Jinwang Li et al.

Summary: Sulforaphane (SFA) has the potential to improve lipid metabolism, inhibit lipid accumulation and apoptosis, making it a potential candidate for preventing and treating nonalcoholic fatty liver disease (NAFLD).

NUTRIENTS (2022)

Article Gastroenterology & Hepatology

A conventional immune regulator mitochondrial antiviral signaling protein blocks hepatic steatosis by maintaining mitochondrial homeostasis

Jiajun Fu et al.

Summary: Although the prevalence of NAFLD has increased to 25% of the adult population worldwide, there are currently no approved pharmacological interventions due to uncertainty about the underlying molecular mechanisms. It has been found that mitochondrial dysfunction plays a crucial role in the development of NAFLD. The mitochondrial antiviral signaling protein (MAVS) has been identified as protective against diet-induced NAFLD, with its deficiency leading to extensive mitochondrial dysfunction. This suggests that targeting MAVS could be a potential avenue for treating NAFLD.

HEPATOLOGY (2022)

Article Medicine, Research & Experimental

Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: Rationale and therapeutic potential

Yukun Zhang et al.

Summary: Idiopathic pulmonary fibrosis (IPF) is a progressive pulmonary disease with unknown causes, and Traditional Chinese Medicine (TCM) has shown advantages in treating IPF globally through a multi-level, multi-target approach. The use of pulmonary drug delivery system (PDDS) can improve the side effects of western medicine and increase drug bioavailability.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Review Plant Sciences

How does traditional knowledge of Cassiae semen shed light on weight management? - A classical and modern literature review

Heidi Yuen et al.

Summary: The seed of Senna obtusifolia (L.) H. S. Irwin & Barneby (Cassiae semen, CS) has been traditionally used in China for weight management and liver support. Modern research has shown that it has weight loss effects and other pharmacological activities supporting weight management. Further studies are needed to explore its potential as a therapeutic agent for overweight and obesity.

JOURNAL OF ETHNOPHARMACOLOGY (2021)

Article Pharmacology & Pharmacy

Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease

Heng Zhang et al.

Summary: Ajugol alleviates high-fat diet-induced hepatic steatosis by promoting TFEB-mediated autophagy-lysosomal pathway and lipophagy. The deficiency of lysosomes is identified as a critical mediator of hepatic steatosis.

PHARMACOLOGICAL RESEARCH (2021)

Article Pharmacology & Pharmacy

Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease

Xiaojiaoyang Li et al.

Summary: The study found that saikosaponin A (SSa) and saikosaponin D (SSd) from Radix Bupleuri can improve nonalcoholic fatty liver disease by modulating glycerolipid metabolism and regulating specific genes. These components also activate certain transcription factors, such as peroxisome proliferator-activated receptor alpha, to regulate fatty acid synthesis and degradation. The results provide critical evidence for the discovery of innovative therapies based on SSa and SSd.

ACTA PHARMACEUTICA SINICA B (2021)

Review Nutrition & Dietetics

AMPK Activity: A Primary Target for Diabetes Prevention with Therapeutic Phytochemicals

Min-Yu Chung et al.

Summary: Natural phytochemicals found in plants have been traditionally used as medicines for preventing chronic diseases like diabetes in East Asia since ancient times. These compounds are characterized as having few side effects, and scientific research has accumulated mounting evidence for their efficacy in preventing metabolic syndrome disorders including diabetes.

NUTRIENTS (2021)

Review Biochemistry & Molecular Biology

Mechanisms and disease consequences of nonalcoholic fatty liver disease

Rohit Loomba et al.

Summary: NAFLD and NASH are leading chronic liver diseases worldwide, causing progressive liver injury that can lead to cirrhosis and hepatocellular carcinoma. These diseases are associated with hepatic glucose and lipid metabolism, and are influenced by genetic, epigenetic, and environmental factors.
Article Biochemistry & Molecular Biology

Reducing FASN expression sensitizes acute myeloid leukemia cells to differentiation therapy

Magali Humbert et al.

Summary: The study found that FASN mRNA levels were significantly higher in acute myeloid leukemia (AML) patients compared to healthy granulocytes or hematopoietic progenitors. Inhibition of FASN expression levels accelerated differentiation of APL cell lines and re-sensitized ATRA refractory non-APL AML cells. FASN reduction promoted translocation of transcription factor EB (TFEB) to the nucleus, leading to activation of CLEAR network genes and lysosomal biogenesis.

CELL DEATH AND DIFFERENTIATION (2021)

Article Biology

Hepatoprotective effects of Cassiae Semen on mice with non-alcoholic fatty liver disease based on gut microbiota

Hanyan Luo et al.

Summary: The study shows that Cassiae Semen and its extracted components can protect against HFD-induced liver injury by ameliorating lipid accumulation, intestinal barrier damage, liver damage, and inflammation, and can also confer their pharmacological effects through fecal microbiome transplantation.

COMMUNICATIONS BIOLOGY (2021)

Article Pharmacology & Pharmacy

Structural Basis for Anti-non-alcoholic Fatty Liver Disease and Diabetic Dyslipidemia Drug Saroglitazar as a PPAR α/γ Dual Agonist

Akihiro Honda et al.

Summary: This study revealed the structural information of saroglitazar and its interaction with PPAR alpha and PPAR gamma, showing differences in their binding modes. The steric hindrance in PPAR gamma-LBD prevents saroglitazar binding, which has implications for the design of PPAR dual or pan agonists.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2021)

Review Pharmacology & Pharmacy

Anti-diabetic drugs and NASH: from current options to promising perspectives

Sarra Smati et al.

Summary: Recent studies have shown promising effects of incretin-based therapies and PPAR agonists on NASH and T2D, highlighting the importance of targeting insulin resistance and metabolic dysfunction. However, the safety profile and limited impact on liver fibrosis of these drugs need to be further evaluated in long-term studies.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)

Article Gastroenterology & Hepatology

Epidemiology and risk-stratification of NAFLD-associated HCC

George N. Ioannou

Summary: NAFLD is projected to be the leading cause of hepatocellular carcinoma and is associated with risk factors such as obesity, diabetes, Hispanic ethnicity, and genetic polymorphisms. Lipotoxicity and oxidative DNA damage may lead to hepatocarcinogenesis, especially in the absence of cirrhosis. Validated models to identify high-risk patients for hepatocellular carcinoma in NAFLD are currently unavailable.

JOURNAL OF HEPATOLOGY (2021)

Editorial Material Cell Biology

Autophagy-independent function of lipidated LC3 essential for TFEB activation during the lysosomal damage responses

Shuhei Nakamura et al.

Summary: Lysosomes play a crucial role in cellular digestion and maintaining cellular homeostasis. Cells have developed defense mechanisms, including the regulation of transcription factors like TFEB and LC3, to cope with damaged lysosomes.

AUTOPHAGY (2021)

Review Gastroenterology & Hepatology

Autophagy in liver diseases: Time for translation?

Manon Allaire et al.

JOURNAL OF HEPATOLOGY (2019)

Review Gastroenterology & Hepatology

Genetics and epigenetics of NAFLD and NASH: Clinical impact

Mohammed Eslam et al.

JOURNAL OF HEPATOLOGY (2018)

Review Biochemistry & Molecular Biology

Mechanisms of NAFLD development and therapeutic strategies

Scott L. Friedman et al.

NATURE MEDICINE (2018)

Review Oncology

Cassiae semen: A review of its phytochemistry and pharmacology

Xiaoxv Dong et al.

MOLECULAR MEDICINE REPORTS (2017)

Review Endocrinology & Metabolism

SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology

Hitoshi Shimano et al.

NATURE REVIEWS ENDOCRINOLOGY (2017)

Review Cell Biology

Autophagy in chronic liver diseases: the two faces of Janus

Philippe Gual et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2017)

Article Gastroenterology & Hepatology

Activation of autophagy protects against acetaminophen-induced hepatotoxicity

Hong-Min Ni et al.

HEPATOLOGY (2012)

Article Multidisciplinary Sciences

Autophagy regulates lipid metabolism

Rajat Singh et al.

NATURE (2009)